Quoin Pharmaceuticals, Ltd. (QNRX) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a topical lotion to treat Netherton Syndrome; QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company was incorporated in 2018 and is based in Ashburn, Virginia.
No case yet. It builds on the next filing, report or 13F period.
No peer readings for Quoin Pharmaceuticals, Ltd. yet.
tall tick = annual report · 1 on record
QNRX (Quoin Pharmaceuticals, Ltd.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
19 managers report a position worth $6.3M between them, and 8 of them hold 80% of it.
Quoin Pharmaceuticals, Ltd.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Manufacturing
Prev close 6.84 · gapped above the open, then crossed back over prior close. High/low 6.88 at 9:30 am ET, 6.61 at 11:30 am ET.